4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004522
President sold 15,000 shares at an average $66.23 ($993,417)
- President acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-01-15 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D: show line 1 in the form |
| RUBINSTEIN JULIE President | 2021-01-15 | Sale | −4,707 | $65.47 | $308,167 | 10,293 | D: show line 2 in the form |
| RUBINSTEIN JULIE President | 2021-01-15 | Sale | −8,802 | $66.47 | $585,069 | 1,491 | D: show line 3 in the form |
| RUBINSTEIN JULIE President | 2021-01-15 | Sale | −1,491 | $67.19 | $100,180 | 0 | D: show line 4 in the form |
| Open-market sales · 15,000 sh · avg $66.23 · $993,417 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-01-15 | Option exercise · Stock Option (Right to Buy) | −15,000 | 230,000 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…